Abstract
The gene regulation of pepsinogens is scientifically interesting, because of the high specificity of expression in gastric chief cells. Also from a clinical point of view pepsinogen gene regulation is interesting. Pepsinogen, activated by acid to pepsin, is one of the aggressive factors in the stomach that play a role in peptic ulcer disease (1). A dominantly inherited high pepsinogen A (PGA) output is associated with duodenal ulcer (2). On the other hand, a low production of pepsinogen A appears to be associated with atrophic gastritis and gastric cancer (3). Changes in gene expression of different isozymogens have been demonstrated in Barrett’s oesophagus (4) and gastric cancer (5). Defize et al. (6) showed, that these changes in gene expression may be associated with methylation of DNA. They demonstrated that N-methyl-N’nitro-N-nitrosoguanidine (MNNG), a methylating agent, caused changes in pepsinogen C (PGC) gene expression in rats and in PGA gene expression in cultured human gastric chief cells. In rats the changes in PGC expression were associated with the development of gastric cancer. Other studies have shown hypomethylation of the pepsinogen genes in pepsinogen producing tissue, i.e. fundic mucosa (7,8). A decrease of PG synthesis in gastric tumours was correlated with a different methylation pattern (9).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
I.M. Samloff, Peptic ulcer: The many proteinases of aggression, Gastroenterology 96:586–95(1989).
J.I. Rotter, I.M. Samloff, G.M. Petersen, Pepsinogen genetics and duodenal ulcer disease, Gut 27:224–226(1986).
B.D. Westerveld, G. Pals, C.B.H.W. Lamers, J. Defize, J.C. Pronk, R.R. Frants, E.C.M. Ooms, J. Kreuning, P. Kostense, A.W. Eriksson, S.G.M. Meuwissen, Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels and serum gastrin levels, Cancer 59:952–958(1987).
G. Pals, A.W. Eriksson, J.C. Pronk et al. Differential expression of pepsinogen isozymogens in a patient with Barrett’s oesophagus, Clin Genet 34:90–7(1988).
G. Pals, B.D. Westerveld, J.C. Pronk, A. Bosma, A.W. Eriksson, S.G.M. Meuwissen, Pepsinogen A isozymogens in normal mucosa and tumor tissue of gastric cancer patients, Neth. J. Med. 28:461–467(1985).
J. Defize, J. Derodra, R.H. Hunt, N-methyl-N’nitro-N-nitroso-guanidine induces changes in rat and human pepsinogen phenotypes, Cancer 62:1958–61(1988).
M. Ichinose, K. Miki, M. Tatematsu, et al. Cell-specific hypomethylation of the pepsinogen gene in pepsinogen-producing cells, Biochem. Biophys. Res. Commun. 155(2):670–7(1988).
M. Ichinose, K. Miki, M. Tatematsu, et al. Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach, Biochem. Biophys. Res. Commun. 151:275–82(1988).
M. Ichinose, K. Miki, R.N.S. Wong, et al. Methylation and expression of human genes in normal tissues and their alteration in stomach cancer, Jpn. J. Cancer. 82:686–92(1991).
P.H.S. Meijerink, J.P. Bebelman, A.M. Oldenburg, J. Defize, R.J. Planta, A.W Eriksson, G. Pals, W.H. Mager, Gastric chief cell-specific transcription of the pepsinogen A gene, Eur. J. Biochem. 213:1283–9(1993).
R.T. Taggart, T.K. Mohandas, T.B. Shows, G.I. Bell, Variable numbers of pepsinogen genes are located in the centromeric region of human chromosome 11 and determine the high frequency electrophoretic polymorphism, Proc. Natl. Acad. Sci. 82:6240–4(1985).
B. Zelle, M.P. Evers, P.C Groot, et al. Genomic structure and evolution of the human pepsinogen A multigene family. Hum Genet 1988;78(l):79–82.
CM. Gorman, LF. Moffat, B.H. Howard, Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells, Mol. Cell. Biol. 2:1044–51(1982).
T. Maniatis, F. Fritsch, J. Sambrook, Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory 1982; Cold Spring Harbor, N.Y.
CM. Gorman, High efficiency gene transfer into mammalian cells. In: DM Glover (ed), DNA cloning, vol 11. IRL press Oxford 1985; pp143–190.
J.P. Bebelman, M.P.J. Evers, B. Zelle, R. Bank, J.C. Pronk, S.G.M. Meuwissen, W.H. Mager, RJ. Planta, A.W. Eriksson, R.R. Frants, Family and population studies on the human pepsinogen A multi gene family, Hum, Genet, 82:142–6(1989).
J. Marsh, M. Ertie, E. Weykes, The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation, Gene 32:481–5(1984).
F. Sanger, S. Nicklen, A.R. Coulson, DNA sequencing with chain terminating inhibitors, Proc. Natl. Acad. Sci. USA. 74:5463–7(1977).
J. Defize, R.H. Hunt, Effect of acid and pepsin on pepsinogen synthesis and secretion in chief cell monolayer cultures, Gut 30:774–81(1989).
J. Defize, F. Arwert, H. Kortbeek, R.R. Frants, S.G.M. Meuwissen, A.W. Eriksson, Pepsinogen synthesis and secretion in monolayer culture of human and rabbit gastric mucosal cells, Virchows Arch. B 49:225–30(1985).
S.G.M. Meuwissen, H. Mullink, A. Bosma, et al. Immunocytochemical localization of pepsinogen A and C in the human stomach, Progr. Clin. Biol. Res. 173:185–198(1985).
P.L. Feigner, T.R. Gadek, M. Holm, et al. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure, Proc. Natl. Acad. Sci. USA, 84:7413–7(1987).
J. Defize, R.H. Hunt, Control of pepsinogen synthesis and secretion in chief cell monolayers, Dig. Dis. Sci. 33:1588–91(1988).
P.H.S. Meijerink, J.P. Bebelman, G. Pals, F. Arwert, R.J. Planta, A.W. Eriksson, WH. Mager, Analysis of the promoter of a human pepsinogen A gene, Adv. Exp. Med. Biol. 306:87–90(1992).
J. Boyd, A. Bird, DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein Cell-64:1123–34(1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pals, G. et al. (1995). Transcription Regulation of Human and Porcine Pepsinogen A. In: Takahashi, K. (eds) Aspartic Proteinases. Advances in Experimental Medicine and Biology, vol 362. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1871-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1871-6_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5761-2
Online ISBN: 978-1-4615-1871-6
eBook Packages: Springer Book Archive